Global Closed System Drug Transfer Device Market

Closed System Drug Transfer Device Comprehensive Study by Type (Membrane-to-membrane Systems, Needleless Systems), Application (Hospitals & Clinics, Oncology Centers, Other End Users), Closing Mechanism (Push-to-Turn Systems, Color-to-Color Alignment Systems, Luer-Lock Systems, Click-to-Lock Systems), Component Type (Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices), Technology Type (Diaphragm-based Devices, Compartmentalized Devices, Air Cleaning/Filtration Devices) Players and Region - Global Market Outlook to 2028

Closed System Drug Transfer Device Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Closed System Drug Transfer Device Market Scope?
Closed System Drug Transfer Device (CSTD) is a medication move gadget that precisely precludes the exchange of natural contaminants into a framework and the departure of dangerous medication or fume fixations outside the framework, which intended to forestall the break of unsafe medication fumes into the earth during drug reconstitution and administration.USA commanded the Closed System Drug Transfer Device (CSTD) and is the biggest creation base. Notwithstanding the USA, there are some other creation territories, for example, Europe. Moreover, the rising adoption of chemotherapy and the improvement of regulatory guidelines regarding hazardous drugs are increasing the market phenomenon.

Influencing Trend:
High Adoption of Phaseal, a Pioneer in the CSTD Market and Rising Adoption of Automation in CSTD

Market Growth Drivers:
Increasing Number of Oncology Drug Approvals and Rising Incidence of Cancer Across the World

Challenges:
The Lack of Regulatory Policies Regarding Health Workers’ Safety in Emerging Countries is Expected to Restrict the Market Growth during the Forecast Period. and Gaps With Existing CSTDs

Restraints:
The flare-up of the pandemic has likewise influenced the CSTD (shut framework drug move gadgets) market over the globe. At present, most of the assembling organizations and examination establishments and focuses are engaged with diagnosing the COVID and antibodies to treat the lethal infection. Hence, the move of clinical gadget and exploration focuses and diagnostics research centers towards the COVID19 pandemic has thwarted the market development.

Opportunities:
Use of CSTDs in Other Therapeutic Areas and Adoption of Cancer Treatment Centers across the World

The Closed System Drug Transfer Device market study is being classified by Type (Membrane-to-membrane Systems and Needleless Systems), by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Closed System Drug Transfer Device market throughout the predicted period.

Becton, Dickinson, and Company (United States), ICU Medical, Inc. (United States), Equashield LLC. (United States), B. Braun Melsungen AG (Germany), Corvida Medical (United States), Baxter International, Inc. (United States), VICTUS (United States), Caragen Ltd. (Ireland) and Simplivia Healthcare (Israel) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Yukon Medical (United States), JMS Co., Ltd. (United States) and CODAN Medizinische Geräte GmbH & Co KG (Germany).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Closed System Drug Transfer Device market by Type, Application and Region.

On the basis of geography, the market of Closed System Drug Transfer Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc. The Smiths Medical business involve syringe and ambulatory infusion devices, vascular access, and vital care products. This acquisition created a scaled US-based global competitor that increases the stability of the medical supply chain and can grow as clinical care models evolve. This acquisition helped company to expand its presence in closed system drug transfer device market
In February 2023, Becton, Dickinson, and Company announced the outcomes of a peer-reviewed study which shows that BD technology used to significantly reduce hazardous drug surface contamination and provide real-time measures to pharmacies and health care facilities. It monitor and improve the safety of health care workers and patients. This clinical study helped Becton, Dickinson, and Company to strengthened its presence in closed system drug transfer device market
NIOSH defines a Closed System Drug-Transfer Device (CSTD) as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system” [NIOSH 2004]. Currently, CSTDs generally follow one of two design concepts, using either a physical barrier or an air-cleaning technology to prevent the escape of hazardous drugs into the work environment. When appropriately designed and used, CSTDs offer enhanced protection against potentially hazardous exposures to healthcare workers during the compounding and administration of hazardous drugs.

Key Target Audience
Manufacturers, Suppliers, Wholesalers, Distributors, and Retailers, Governmental bodies and Others

Closed System Drug Transfer Device Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Closed System Drug Transfer Device Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Closed System Drug Transfer Device industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Membrane-to-membrane Systems
  • Needleless Systems
By Application
  • Hospitals & Clinics
  • Oncology Centers
  • Other End Users
By Closing Mechanism
  • Push-to-Turn Systems
  • Color-to-Color Alignment Systems
  • Luer-Lock Systems
  • Click-to-Lock Systems

By Component Type
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag/Line Access Devices

By Technology Type
  • Diaphragm-based Devices
  • Compartmentalized Devices
  • Air Cleaning/Filtration Devices

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Oncology Drug Approvals
      • 3.2.2. Rising Incidence of Cancer Across the World
    • 3.3. Market Challenges
      • 3.3.1. The Lack of Regulatory Policies Regarding Health Workers’ Safety in Emerging Countries is Expected to Restrict the Market Growth during the Forecast Period.
      • 3.3.2. Gaps With Existing CSTDs
    • 3.4. Market Trends
      • 3.4.1. High Adoption of Phaseal, a Pioneer in the CSTD Market
      • 3.4.2. Rising Adoption of Automation in CSTD
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Closed System Drug Transfer Device, by Type, Application, Closing Mechanism, Component Type, Technology Type and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Closed System Drug Transfer Device (Value)
      • 5.2.1. Global Closed System Drug Transfer Device by: Type (Value)
        • 5.2.1.1. Membrane-to-membrane Systems
        • 5.2.1.2. Needleless Systems
      • 5.2.2. Global Closed System Drug Transfer Device by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Oncology Centers
        • 5.2.2.3. Other End Users
      • 5.2.3. Global Closed System Drug Transfer Device by: Closing Mechanism (Value)
        • 5.2.3.1. Push-to-Turn Systems
        • 5.2.3.2. Color-to-Color Alignment Systems
        • 5.2.3.3. Luer-Lock Systems
        • 5.2.3.4. Click-to-Lock Systems
      • 5.2.4. Global Closed System Drug Transfer Device by: Component Type (Value)
        • 5.2.4.1. Closed Vial Access Devices
        • 5.2.4.2. Closed Syringe Safety Devices
        • 5.2.4.3. Closed Bag/Line Access Devices
      • 5.2.5. Global Closed System Drug Transfer Device by: Technology Type (Value)
        • 5.2.5.1. Diaphragm-based Devices
        • 5.2.5.2. Compartmentalized Devices
        • 5.2.5.3. Air Cleaning/Filtration Devices
      • 5.2.6. Global Closed System Drug Transfer Device Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Closed System Drug Transfer Device (Volume)
      • 5.3.1. Global Closed System Drug Transfer Device by: Type (Volume)
        • 5.3.1.1. Membrane-to-membrane Systems
        • 5.3.1.2. Needleless Systems
      • 5.3.2. Global Closed System Drug Transfer Device by: Application (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Oncology Centers
        • 5.3.2.3. Other End Users
      • 5.3.3. Global Closed System Drug Transfer Device by: Closing Mechanism (Volume)
        • 5.3.3.1. Push-to-Turn Systems
        • 5.3.3.2. Color-to-Color Alignment Systems
        • 5.3.3.3. Luer-Lock Systems
        • 5.3.3.4. Click-to-Lock Systems
      • 5.3.4. Global Closed System Drug Transfer Device by: Component Type (Volume)
        • 5.3.4.1. Closed Vial Access Devices
        • 5.3.4.2. Closed Syringe Safety Devices
        • 5.3.4.3. Closed Bag/Line Access Devices
      • 5.3.5. Global Closed System Drug Transfer Device by: Technology Type (Volume)
        • 5.3.5.1. Diaphragm-based Devices
        • 5.3.5.2. Compartmentalized Devices
        • 5.3.5.3. Air Cleaning/Filtration Devices
      • 5.3.6. Global Closed System Drug Transfer Device Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Closed System Drug Transfer Device (Price)
      • 5.4.1. Global Closed System Drug Transfer Device by: Type (Price)
  • 6. Closed System Drug Transfer Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson, and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ICU Medical, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Equashield LLC. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Melsungen AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Corvida Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Baxter International, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. VICTUS (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Caragen Ltd. (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Simplivia Healthcare (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Closed System Drug Transfer Device Sale, by Type, Application, Closing Mechanism, Component Type, Technology Type and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Closed System Drug Transfer Device (Value)
      • 7.2.1. Global Closed System Drug Transfer Device by: Type (Value)
        • 7.2.1.1. Membrane-to-membrane Systems
        • 7.2.1.2. Needleless Systems
      • 7.2.2. Global Closed System Drug Transfer Device by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Oncology Centers
        • 7.2.2.3. Other End Users
      • 7.2.3. Global Closed System Drug Transfer Device by: Closing Mechanism (Value)
        • 7.2.3.1. Push-to-Turn Systems
        • 7.2.3.2. Color-to-Color Alignment Systems
        • 7.2.3.3. Luer-Lock Systems
        • 7.2.3.4. Click-to-Lock Systems
      • 7.2.4. Global Closed System Drug Transfer Device by: Component Type (Value)
        • 7.2.4.1. Closed Vial Access Devices
        • 7.2.4.2. Closed Syringe Safety Devices
        • 7.2.4.3. Closed Bag/Line Access Devices
      • 7.2.5. Global Closed System Drug Transfer Device by: Technology Type (Value)
        • 7.2.5.1. Diaphragm-based Devices
        • 7.2.5.2. Compartmentalized Devices
        • 7.2.5.3. Air Cleaning/Filtration Devices
      • 7.2.6. Global Closed System Drug Transfer Device Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Closed System Drug Transfer Device (Volume)
      • 7.3.1. Global Closed System Drug Transfer Device by: Type (Volume)
        • 7.3.1.1. Membrane-to-membrane Systems
        • 7.3.1.2. Needleless Systems
      • 7.3.2. Global Closed System Drug Transfer Device by: Application (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Oncology Centers
        • 7.3.2.3. Other End Users
      • 7.3.3. Global Closed System Drug Transfer Device by: Closing Mechanism (Volume)
        • 7.3.3.1. Push-to-Turn Systems
        • 7.3.3.2. Color-to-Color Alignment Systems
        • 7.3.3.3. Luer-Lock Systems
        • 7.3.3.4. Click-to-Lock Systems
      • 7.3.4. Global Closed System Drug Transfer Device by: Component Type (Volume)
        • 7.3.4.1. Closed Vial Access Devices
        • 7.3.4.2. Closed Syringe Safety Devices
        • 7.3.4.3. Closed Bag/Line Access Devices
      • 7.3.5. Global Closed System Drug Transfer Device by: Technology Type (Volume)
        • 7.3.5.1. Diaphragm-based Devices
        • 7.3.5.2. Compartmentalized Devices
        • 7.3.5.3. Air Cleaning/Filtration Devices
      • 7.3.6. Global Closed System Drug Transfer Device Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Closed System Drug Transfer Device (Price)
      • 7.4.1. Global Closed System Drug Transfer Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Closed System Drug Transfer Device: by Type(USD Million)
  • Table 2. Closed System Drug Transfer Device Membrane-to-membrane Systems , by Region USD Million (2017-2022)
  • Table 3. Closed System Drug Transfer Device Needleless Systems , by Region USD Million (2017-2022)
  • Table 4. Closed System Drug Transfer Device: by Application(USD Million)
  • Table 5. Closed System Drug Transfer Device Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 6. Closed System Drug Transfer Device Oncology Centers , by Region USD Million (2017-2022)
  • Table 7. Closed System Drug Transfer Device Other End Users , by Region USD Million (2017-2022)
  • Table 8. Closed System Drug Transfer Device: by Closing Mechanism(USD Million)
  • Table 9. Closed System Drug Transfer Device Push-to-Turn Systems , by Region USD Million (2017-2022)
  • Table 10. Closed System Drug Transfer Device Color-to-Color Alignment Systems , by Region USD Million (2017-2022)
  • Table 11. Closed System Drug Transfer Device Luer-Lock Systems , by Region USD Million (2017-2022)
  • Table 12. Closed System Drug Transfer Device Click-to-Lock Systems , by Region USD Million (2017-2022)
  • Table 13. Closed System Drug Transfer Device: by Component Type(USD Million)
  • Table 14. Closed System Drug Transfer Device Closed Vial Access Devices , by Region USD Million (2017-2022)
  • Table 15. Closed System Drug Transfer Device Closed Syringe Safety Devices , by Region USD Million (2017-2022)
  • Table 16. Closed System Drug Transfer Device Closed Bag/Line Access Devices , by Region USD Million (2017-2022)
  • Table 17. Closed System Drug Transfer Device: by Technology Type(USD Million)
  • Table 18. Closed System Drug Transfer Device Diaphragm-based Devices , by Region USD Million (2017-2022)
  • Table 19. Closed System Drug Transfer Device Compartmentalized Devices , by Region USD Million (2017-2022)
  • Table 20. Closed System Drug Transfer Device Air Cleaning/Filtration Devices , by Region USD Million (2017-2022)
  • Table 21. South America Closed System Drug Transfer Device, by Country USD Million (2017-2022)
  • Table 22. South America Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 23. South America Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 24. South America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 25. South America Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 26. South America Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 27. Brazil Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 28. Brazil Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 29. Brazil Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 30. Brazil Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 31. Brazil Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 32. Argentina Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 33. Argentina Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 34. Argentina Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 35. Argentina Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 36. Argentina Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 37. Rest of South America Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 38. Rest of South America Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 39. Rest of South America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 40. Rest of South America Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 41. Rest of South America Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 42. Asia Pacific Closed System Drug Transfer Device, by Country USD Million (2017-2022)
  • Table 43. Asia Pacific Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 44. Asia Pacific Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 45. Asia Pacific Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 46. Asia Pacific Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 47. Asia Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 48. China Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 49. China Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 50. China Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 51. China Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 52. China Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 53. Japan Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 54. Japan Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 55. Japan Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 56. Japan Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 57. Japan Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 58. India Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 59. India Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 60. India Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 61. India Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 62. India Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 63. South Korea Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 64. South Korea Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 65. South Korea Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 66. South Korea Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 67. South Korea Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 68. Taiwan Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 69. Taiwan Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 70. Taiwan Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 71. Taiwan Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 72. Taiwan Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 73. Australia Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 74. Australia Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 75. Australia Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 76. Australia Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 77. Australia Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 83. Europe Closed System Drug Transfer Device, by Country USD Million (2017-2022)
  • Table 84. Europe Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 85. Europe Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 86. Europe Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 87. Europe Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 88. Europe Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 89. Germany Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 90. Germany Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 91. Germany Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 92. Germany Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 93. Germany Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 94. France Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 95. France Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 96. France Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 97. France Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 98. France Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 99. Italy Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 100. Italy Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 101. Italy Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 102. Italy Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 103. Italy Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 104. United Kingdom Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 105. United Kingdom Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 106. United Kingdom Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 107. United Kingdom Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 108. United Kingdom Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 109. Netherlands Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 110. Netherlands Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 111. Netherlands Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 112. Netherlands Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 113. Netherlands Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 114. Rest of Europe Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 115. Rest of Europe Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 116. Rest of Europe Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 117. Rest of Europe Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 118. Rest of Europe Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 119. MEA Closed System Drug Transfer Device, by Country USD Million (2017-2022)
  • Table 120. MEA Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 121. MEA Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 122. MEA Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 123. MEA Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 124. MEA Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 125. Middle East Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 126. Middle East Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 127. Middle East Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 128. Middle East Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 129. Middle East Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 130. Africa Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 131. Africa Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 132. Africa Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 133. Africa Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 134. Africa Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 135. North America Closed System Drug Transfer Device, by Country USD Million (2017-2022)
  • Table 136. North America Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 137. North America Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 138. North America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 139. North America Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 140. North America Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 141. United States Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 142. United States Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 143. United States Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 144. United States Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 145. United States Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 146. Canada Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 147. Canada Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 148. Canada Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 149. Canada Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 150. Canada Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 151. Mexico Closed System Drug Transfer Device, by Type USD Million (2017-2022)
  • Table 152. Mexico Closed System Drug Transfer Device, by Application USD Million (2017-2022)
  • Table 153. Mexico Closed System Drug Transfer Device, by Closing Mechanism USD Million (2017-2022)
  • Table 154. Mexico Closed System Drug Transfer Device, by Component Type USD Million (2017-2022)
  • Table 155. Mexico Closed System Drug Transfer Device, by Technology Type USD Million (2017-2022)
  • Table 156. Closed System Drug Transfer Device Sales: by Type(UNIT)
  • Table 157. Closed System Drug Transfer Device Sales Membrane-to-membrane Systems , by Region UNIT (2017-2022)
  • Table 158. Closed System Drug Transfer Device Sales Needleless Systems , by Region UNIT (2017-2022)
  • Table 159. Closed System Drug Transfer Device Sales: by Application(UNIT)
  • Table 160. Closed System Drug Transfer Device Sales Hospitals & Clinics , by Region UNIT (2017-2022)
  • Table 161. Closed System Drug Transfer Device Sales Oncology Centers , by Region UNIT (2017-2022)
  • Table 162. Closed System Drug Transfer Device Sales Other End Users , by Region UNIT (2017-2022)
  • Table 163. Closed System Drug Transfer Device Sales: by Closing Mechanism(UNIT)
  • Table 164. Closed System Drug Transfer Device Sales Push-to-Turn Systems , by Region UNIT (2017-2022)
  • Table 165. Closed System Drug Transfer Device Sales Color-to-Color Alignment Systems , by Region UNIT (2017-2022)
  • Table 166. Closed System Drug Transfer Device Sales Luer-Lock Systems , by Region UNIT (2017-2022)
  • Table 167. Closed System Drug Transfer Device Sales Click-to-Lock Systems , by Region UNIT (2017-2022)
  • Table 168. Closed System Drug Transfer Device Sales: by Component Type(UNIT)
  • Table 169. Closed System Drug Transfer Device Sales Closed Vial Access Devices , by Region UNIT (2017-2022)
  • Table 170. Closed System Drug Transfer Device Sales Closed Syringe Safety Devices , by Region UNIT (2017-2022)
  • Table 171. Closed System Drug Transfer Device Sales Closed Bag/Line Access Devices , by Region UNIT (2017-2022)
  • Table 172. Closed System Drug Transfer Device Sales: by Technology Type(UNIT)
  • Table 173. Closed System Drug Transfer Device Sales Diaphragm-based Devices , by Region UNIT (2017-2022)
  • Table 174. Closed System Drug Transfer Device Sales Compartmentalized Devices , by Region UNIT (2017-2022)
  • Table 175. Closed System Drug Transfer Device Sales Air Cleaning/Filtration Devices , by Region UNIT (2017-2022)
  • Table 176. South America Closed System Drug Transfer Device Sales, by Country UNIT (2017-2022)
  • Table 177. South America Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 178. South America Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 179. South America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 180. South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 181. South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 182. Brazil Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 183. Brazil Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 184. Brazil Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 185. Brazil Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 186. Brazil Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 187. Argentina Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 188. Argentina Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 189. Argentina Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 190. Argentina Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 191. Argentina Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 192. Rest of South America Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 193. Rest of South America Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 194. Rest of South America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 195. Rest of South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 196. Rest of South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 197. Asia Pacific Closed System Drug Transfer Device Sales, by Country UNIT (2017-2022)
  • Table 198. Asia Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 199. Asia Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 200. Asia Pacific Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 201. Asia Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 202. Asia Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 203. China Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 204. China Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 205. China Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 206. China Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 207. China Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 208. Japan Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 209. Japan Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 210. Japan Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 211. Japan Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 212. Japan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 213. India Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 214. India Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 215. India Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 216. India Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 217. India Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 218. South Korea Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 219. South Korea Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 220. South Korea Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 221. South Korea Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 222. South Korea Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 223. Taiwan Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 224. Taiwan Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 225. Taiwan Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 226. Taiwan Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 227. Taiwan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 228. Australia Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 229. Australia Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 230. Australia Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 231. Australia Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 232. Australia Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 233. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 234. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 235. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 236. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 237. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 238. Europe Closed System Drug Transfer Device Sales, by Country UNIT (2017-2022)
  • Table 239. Europe Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 240. Europe Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 241. Europe Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 242. Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 243. Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 244. Germany Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 245. Germany Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 246. Germany Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 247. Germany Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 248. Germany Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 249. France Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 250. France Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 251. France Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 252. France Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 253. France Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 254. Italy Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 255. Italy Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 256. Italy Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 257. Italy Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 258. Italy Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 259. United Kingdom Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 260. United Kingdom Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 261. United Kingdom Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 262. United Kingdom Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 263. United Kingdom Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 264. Netherlands Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 265. Netherlands Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 266. Netherlands Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 267. Netherlands Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 268. Netherlands Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 269. Rest of Europe Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 270. Rest of Europe Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 271. Rest of Europe Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 272. Rest of Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 273. Rest of Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 274. MEA Closed System Drug Transfer Device Sales, by Country UNIT (2017-2022)
  • Table 275. MEA Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 276. MEA Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 277. MEA Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 278. MEA Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 279. MEA Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 280. Middle East Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 281. Middle East Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 282. Middle East Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 283. Middle East Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 284. Middle East Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 285. Africa Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 286. Africa Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 287. Africa Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 288. Africa Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 289. Africa Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 290. North America Closed System Drug Transfer Device Sales, by Country UNIT (2017-2022)
  • Table 291. North America Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 292. North America Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 293. North America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 294. North America Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 295. North America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 296. United States Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 297. United States Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 298. United States Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 299. United States Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 300. United States Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 301. Canada Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 302. Canada Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 303. Canada Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 304. Canada Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 305. Canada Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 306. Mexico Closed System Drug Transfer Device Sales, by Type UNIT (2017-2022)
  • Table 307. Mexico Closed System Drug Transfer Device Sales, by Application UNIT (2017-2022)
  • Table 308. Mexico Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2017-2022)
  • Table 309. Mexico Closed System Drug Transfer Device Sales, by Component Type UNIT (2017-2022)
  • Table 310. Mexico Closed System Drug Transfer Device Sales, by Technology Type UNIT (2017-2022)
  • Table 311. Closed System Drug Transfer Device: by Type(USD/Units)
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Closed System Drug Transfer Device: by Type(USD Million)
  • Table 322. Closed System Drug Transfer Device Membrane-to-membrane Systems , by Region USD Million (2023-2028)
  • Table 323. Closed System Drug Transfer Device Needleless Systems , by Region USD Million (2023-2028)
  • Table 324. Closed System Drug Transfer Device: by Application(USD Million)
  • Table 325. Closed System Drug Transfer Device Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 326. Closed System Drug Transfer Device Oncology Centers , by Region USD Million (2023-2028)
  • Table 327. Closed System Drug Transfer Device Other End Users , by Region USD Million (2023-2028)
  • Table 328. Closed System Drug Transfer Device: by Closing Mechanism(USD Million)
  • Table 329. Closed System Drug Transfer Device Push-to-Turn Systems , by Region USD Million (2023-2028)
  • Table 330. Closed System Drug Transfer Device Color-to-Color Alignment Systems , by Region USD Million (2023-2028)
  • Table 331. Closed System Drug Transfer Device Luer-Lock Systems , by Region USD Million (2023-2028)
  • Table 332. Closed System Drug Transfer Device Click-to-Lock Systems , by Region USD Million (2023-2028)
  • Table 333. Closed System Drug Transfer Device: by Component Type(USD Million)
  • Table 334. Closed System Drug Transfer Device Closed Vial Access Devices , by Region USD Million (2023-2028)
  • Table 335. Closed System Drug Transfer Device Closed Syringe Safety Devices , by Region USD Million (2023-2028)
  • Table 336. Closed System Drug Transfer Device Closed Bag/Line Access Devices , by Region USD Million (2023-2028)
  • Table 337. Closed System Drug Transfer Device: by Technology Type(USD Million)
  • Table 338. Closed System Drug Transfer Device Diaphragm-based Devices , by Region USD Million (2023-2028)
  • Table 339. Closed System Drug Transfer Device Compartmentalized Devices , by Region USD Million (2023-2028)
  • Table 340. Closed System Drug Transfer Device Air Cleaning/Filtration Devices , by Region USD Million (2023-2028)
  • Table 341. South America Closed System Drug Transfer Device, by Country USD Million (2023-2028)
  • Table 342. South America Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 343. South America Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 344. South America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 345. South America Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 346. South America Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 347. Brazil Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 348. Brazil Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 349. Brazil Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 350. Brazil Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 351. Brazil Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 352. Argentina Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 353. Argentina Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 354. Argentina Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 355. Argentina Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 356. Argentina Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 357. Rest of South America Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 358. Rest of South America Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 359. Rest of South America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 360. Rest of South America Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 361. Rest of South America Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 362. Asia Pacific Closed System Drug Transfer Device, by Country USD Million (2023-2028)
  • Table 363. Asia Pacific Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 364. Asia Pacific Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 365. Asia Pacific Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 366. Asia Pacific Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 367. Asia Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 368. China Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 369. China Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 370. China Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 371. China Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 372. China Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 373. Japan Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 374. Japan Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 375. Japan Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 376. Japan Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 377. Japan Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 378. India Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 379. India Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 380. India Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 381. India Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 382. India Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 383. South Korea Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 384. South Korea Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 385. South Korea Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 386. South Korea Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 387. South Korea Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 388. Taiwan Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 389. Taiwan Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 390. Taiwan Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 391. Taiwan Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 392. Taiwan Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 393. Australia Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 394. Australia Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 395. Australia Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 396. Australia Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 397. Australia Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 398. Rest of Asia-Pacific Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 399. Rest of Asia-Pacific Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 400. Rest of Asia-Pacific Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 401. Rest of Asia-Pacific Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 402. Rest of Asia-Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 403. Europe Closed System Drug Transfer Device, by Country USD Million (2023-2028)
  • Table 404. Europe Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 405. Europe Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 406. Europe Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 407. Europe Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 408. Europe Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 409. Germany Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 410. Germany Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 411. Germany Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 412. Germany Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 413. Germany Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 414. France Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 415. France Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 416. France Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 417. France Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 418. France Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 419. Italy Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 420. Italy Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 421. Italy Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 422. Italy Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 423. Italy Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 424. United Kingdom Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 425. United Kingdom Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 426. United Kingdom Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 427. United Kingdom Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 428. United Kingdom Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 429. Netherlands Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 430. Netherlands Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 431. Netherlands Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 432. Netherlands Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 433. Netherlands Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 434. Rest of Europe Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 435. Rest of Europe Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 436. Rest of Europe Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 437. Rest of Europe Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 438. Rest of Europe Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 439. MEA Closed System Drug Transfer Device, by Country USD Million (2023-2028)
  • Table 440. MEA Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 441. MEA Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 442. MEA Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 443. MEA Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 444. MEA Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 445. Middle East Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 446. Middle East Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 447. Middle East Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 448. Middle East Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 449. Middle East Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 450. Africa Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 451. Africa Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 452. Africa Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 453. Africa Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 454. Africa Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 455. North America Closed System Drug Transfer Device, by Country USD Million (2023-2028)
  • Table 456. North America Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 457. North America Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 458. North America Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 459. North America Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 460. North America Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 461. United States Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 462. United States Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 463. United States Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 464. United States Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 465. United States Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 466. Canada Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 467. Canada Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 468. Canada Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 469. Canada Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 470. Canada Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 471. Mexico Closed System Drug Transfer Device, by Type USD Million (2023-2028)
  • Table 472. Mexico Closed System Drug Transfer Device, by Application USD Million (2023-2028)
  • Table 473. Mexico Closed System Drug Transfer Device, by Closing Mechanism USD Million (2023-2028)
  • Table 474. Mexico Closed System Drug Transfer Device, by Component Type USD Million (2023-2028)
  • Table 475. Mexico Closed System Drug Transfer Device, by Technology Type USD Million (2023-2028)
  • Table 476. Closed System Drug Transfer Device Sales: by Type(UNIT)
  • Table 477. Closed System Drug Transfer Device Sales Membrane-to-membrane Systems , by Region UNIT (2023-2028)
  • Table 478. Closed System Drug Transfer Device Sales Needleless Systems , by Region UNIT (2023-2028)
  • Table 479. Closed System Drug Transfer Device Sales: by Application(UNIT)
  • Table 480. Closed System Drug Transfer Device Sales Hospitals & Clinics , by Region UNIT (2023-2028)
  • Table 481. Closed System Drug Transfer Device Sales Oncology Centers , by Region UNIT (2023-2028)
  • Table 482. Closed System Drug Transfer Device Sales Other End Users , by Region UNIT (2023-2028)
  • Table 483. Closed System Drug Transfer Device Sales: by Closing Mechanism(UNIT)
  • Table 484. Closed System Drug Transfer Device Sales Push-to-Turn Systems , by Region UNIT (2023-2028)
  • Table 485. Closed System Drug Transfer Device Sales Color-to-Color Alignment Systems , by Region UNIT (2023-2028)
  • Table 486. Closed System Drug Transfer Device Sales Luer-Lock Systems , by Region UNIT (2023-2028)
  • Table 487. Closed System Drug Transfer Device Sales Click-to-Lock Systems , by Region UNIT (2023-2028)
  • Table 488. Closed System Drug Transfer Device Sales: by Component Type(UNIT)
  • Table 489. Closed System Drug Transfer Device Sales Closed Vial Access Devices , by Region UNIT (2023-2028)
  • Table 490. Closed System Drug Transfer Device Sales Closed Syringe Safety Devices , by Region UNIT (2023-2028)
  • Table 491. Closed System Drug Transfer Device Sales Closed Bag/Line Access Devices , by Region UNIT (2023-2028)
  • Table 492. Closed System Drug Transfer Device Sales: by Technology Type(UNIT)
  • Table 493. Closed System Drug Transfer Device Sales Diaphragm-based Devices , by Region UNIT (2023-2028)
  • Table 494. Closed System Drug Transfer Device Sales Compartmentalized Devices , by Region UNIT (2023-2028)
  • Table 495. Closed System Drug Transfer Device Sales Air Cleaning/Filtration Devices , by Region UNIT (2023-2028)
  • Table 496. South America Closed System Drug Transfer Device Sales, by Country UNIT (2023-2028)
  • Table 497. South America Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 498. South America Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 499. South America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 500. South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 501. South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 502. Brazil Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 503. Brazil Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 504. Brazil Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 505. Brazil Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 506. Brazil Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 507. Argentina Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 508. Argentina Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 509. Argentina Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 510. Argentina Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 511. Argentina Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 512. Rest of South America Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 513. Rest of South America Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 514. Rest of South America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 515. Rest of South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 516. Rest of South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 517. Asia Pacific Closed System Drug Transfer Device Sales, by Country UNIT (2023-2028)
  • Table 518. Asia Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 519. Asia Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 520. Asia Pacific Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 521. Asia Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 522. Asia Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 523. China Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 524. China Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 525. China Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 526. China Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 527. China Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 528. Japan Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 529. Japan Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 530. Japan Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 531. Japan Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 532. Japan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 533. India Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 534. India Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 535. India Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 536. India Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 537. India Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 538. South Korea Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 539. South Korea Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 540. South Korea Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 541. South Korea Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 542. South Korea Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 543. Taiwan Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 544. Taiwan Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 545. Taiwan Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 546. Taiwan Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 547. Taiwan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 548. Australia Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 549. Australia Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 550. Australia Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 551. Australia Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 552. Australia Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 553. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 554. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 555. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 556. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 557. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 558. Europe Closed System Drug Transfer Device Sales, by Country UNIT (2023-2028)
  • Table 559. Europe Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 560. Europe Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 561. Europe Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 562. Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 563. Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 564. Germany Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 565. Germany Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 566. Germany Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 567. Germany Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 568. Germany Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 569. France Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 570. France Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 571. France Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 572. France Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 573. France Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 574. Italy Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 575. Italy Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 576. Italy Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 577. Italy Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 578. Italy Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 579. United Kingdom Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 580. United Kingdom Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 581. United Kingdom Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 582. United Kingdom Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 583. United Kingdom Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 584. Netherlands Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 585. Netherlands Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 586. Netherlands Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 587. Netherlands Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 588. Netherlands Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 589. Rest of Europe Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 590. Rest of Europe Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 591. Rest of Europe Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 592. Rest of Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 593. Rest of Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 594. MEA Closed System Drug Transfer Device Sales, by Country UNIT (2023-2028)
  • Table 595. MEA Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 596. MEA Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 597. MEA Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 598. MEA Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 599. MEA Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 600. Middle East Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 601. Middle East Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 602. Middle East Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 603. Middle East Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 604. Middle East Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 605. Africa Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 606. Africa Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 607. Africa Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 608. Africa Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 609. Africa Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 610. North America Closed System Drug Transfer Device Sales, by Country UNIT (2023-2028)
  • Table 611. North America Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 612. North America Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 613. North America Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 614. North America Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 615. North America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 616. United States Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 617. United States Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 618. United States Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 619. United States Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 620. United States Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 621. Canada Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 622. Canada Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
  • Table 623. Canada Closed System Drug Transfer Device Sales, by Closing Mechanism UNIT (2023-2028)
  • Table 624. Canada Closed System Drug Transfer Device Sales, by Component Type UNIT (2023-2028)
  • Table 625. Canada Closed System Drug Transfer Device Sales, by Technology Type UNIT (2023-2028)
  • Table 626. Mexico Closed System Drug Transfer Device Sales, by Type UNIT (2023-2028)
  • Table 627. Mexico Closed System Drug Transfer Device Sales, by Application UNIT (2023-2028)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Closed System Drug Transfer Device: by Type USD Million (2017-2022)
  • Figure 5. Global Closed System Drug Transfer Device: by Application USD Million (2017-2022)
  • Figure 6. Global Closed System Drug Transfer Device: by Closing Mechanism USD Million (2017-2022)
  • Figure 7. Global Closed System Drug Transfer Device: by Component Type USD Million (2017-2022)
  • Figure 8. Global Closed System Drug Transfer Device: by Technology Type USD Million (2017-2022)
  • Figure 9. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 10. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 11. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 12. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 13. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 14. Global Closed System Drug Transfer Device: by Type UNIT (2017-2022)
  • Figure 15. Global Closed System Drug Transfer Device: by Application UNIT (2017-2022)
  • Figure 16. Global Closed System Drug Transfer Device: by Closing Mechanism UNIT (2017-2022)
  • Figure 17. Global Closed System Drug Transfer Device: by Component Type UNIT (2017-2022)
  • Figure 18. Global Closed System Drug Transfer Device: by Technology Type UNIT (2017-2022)
  • Figure 19. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 20. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 21. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 22. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 23. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 24. Global Closed System Drug Transfer Device: by Type USD/Units (2017-2022)
  • Figure 25. Global Closed System Drug Transfer Device share by Players 2022 (%)
  • Figure 26. Global Closed System Drug Transfer Device share by Players (Top 3) 2022(%)
  • Figure 27. Global Closed System Drug Transfer Device share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. Becton, Dickinson, and Company (United States) Revenue: by Geography 2022
  • Figure 31. ICU Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. ICU Medical, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Equashield LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Equashield LLC. (United States) Revenue: by Geography 2022
  • Figure 35. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. B. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 37. Corvida Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Corvida Medical (United States) Revenue: by Geography 2022
  • Figure 39. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Baxter International, Inc. (United States) Revenue: by Geography 2022
  • Figure 41. VICTUS (United States) Revenue, Net Income and Gross profit
  • Figure 42. VICTUS (United States) Revenue: by Geography 2022
  • Figure 43. Caragen Ltd. (Ireland) Revenue, Net Income and Gross profit
  • Figure 44. Caragen Ltd. (Ireland) Revenue: by Geography 2022
  • Figure 45. Simplivia Healthcare (Israel) Revenue, Net Income and Gross profit
  • Figure 46. Simplivia Healthcare (Israel) Revenue: by Geography 2022
  • Figure 47. Global Closed System Drug Transfer Device: by Type USD Million (2023-2028)
  • Figure 48. Global Closed System Drug Transfer Device: by Application USD Million (2023-2028)
  • Figure 49. Global Closed System Drug Transfer Device: by Closing Mechanism USD Million (2023-2028)
  • Figure 50. Global Closed System Drug Transfer Device: by Component Type USD Million (2023-2028)
  • Figure 51. Global Closed System Drug Transfer Device: by Technology Type USD Million (2023-2028)
  • Figure 52. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 53. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 54. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 55. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 56. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 57. Global Closed System Drug Transfer Device: by Type UNIT (2023-2028)
  • Figure 58. Global Closed System Drug Transfer Device: by Application UNIT (2023-2028)
  • Figure 59. Global Closed System Drug Transfer Device: by Closing Mechanism UNIT (2023-2028)
  • Figure 60. Global Closed System Drug Transfer Device: by Component Type UNIT (2023-2028)
  • Figure 61. Global Closed System Drug Transfer Device: by Technology Type UNIT (2023-2028)
  • Figure 62. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 63. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 64. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 65. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 66. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 67. Global Closed System Drug Transfer Device: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson, and Company (United States)
  • ICU Medical, Inc. (United States)
  • Equashield LLC. (United States)
  • B. Braun Melsungen AG (Germany)
  • Corvida Medical (United States)
  • Baxter International, Inc. (United States)
  • VICTUS (United States)
  • Caragen Ltd. (Ireland)
  • Simplivia Healthcare (Israel)
Additional players considered in the study are as follows:
Yukon Medical (United States) , JMS Co., Ltd. (United States) , CODAN Medizinische Geräte GmbH & Co KG (Germany)
Select User Access Type

Key Highlights of Report


May 2023 205 Pages 95 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Closed System Drug Transfer Device Market Quantitative research analysis
Global Closed System Drug Transfer Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Closed System Drug Transfer Device market are Becton, Dickinson, and Company (United States), ICU Medical, Inc. (United States), Equashield LLC. (United States), B. Braun Melsungen AG (Germany), Corvida Medical (United States), Baxter International, Inc. (United States), VICTUS (United States), Caragen Ltd. (Ireland) and Simplivia Healthcare (Israel).
In this highly competitive & fast evolving Closed System Drug Transfer Device industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Hospitals & Clinics, Oncology Centers and Other End Users are the potential customers of Closed System Drug Transfer Device industry.

Know More About Global Closed System Drug Transfer Device Market Report?

Have a Query? Click Here

Other Related Reports

Disposable Plastic Blood Bag Comprehensive Study by Type (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, Others), Application (Blood Banks, Hospitals, Clinics, Others)...
$ 3450
Tongue Depressors Comprehensive Study by Type (Reusable, Disposable), Distribution Channel (Online, Offline), Material Type (Wooden, Metal, Plastic), End-Use (Hospitals, Dental Clinics, Academic & Re...
$ 3350
Hearing Aids Comprehensive Study by Type (In the ear hearing aids (ITE), In the canal (ITC), Completely in the canal (CIC), Behind the ear (BTE), Receiver in canal (RIC)), Distribution Channel (Onlin...
$ 3650
UV Infection Control Device Comprehensive Study by Type (Mobile Type, Stationary Type, Others), Application (Immunodiagnostics, Molecular Diagnostics, Others), End Use (Hospitals, Medical Device Comp...
$ 3450
Body Composition Analyzers Comprehensive Study by Type (Bio-impedance Analyzer, Dual Energy X-ray Absorptiometry Equipment, Skinfold Calipers, Air Displacement Plethysmography Equipment, Hydrostatic ...
$ 3650
Bio-Electronic Comprehensive Study by Type (Bio-Electronic Devices, Bio-Electronic Medicine), Application (Biochips, Implantable Medical Devices, Prosthetic Devices, Artificial Organs/Bionic Organs, ...
$ 3450